Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brainsway Ltd (BWAY)
NASDAQ:BWAY
BWAY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.61 - $11.79
Previous CloseN/A
Volume9.67K
Average Volume (3M)65.63K
Market Cap
$214.75M
Enterprise Value$105.72M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)125.3
Beta1.67
Next Earnings
Apr 01, 2025EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding18,827,324
10 Day Avg. Volume83,286
30 Day Avg. Volume65,631
Standard Deviation0.20
R-Squared0.11
Alpha0.00206
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)20.90
Price to Cash Flow (P/CF)19.10
P/FCF Ratio0.00
Enterprise Value/Market Cap0.49
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.50
Enterprise Value/Ebitda23.83
Forecast
1Y Price Target
$16.00Price Target Upside48.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Brainsway News
PremiumCompany Announcements
BrainsWay’s Deep TMS Shows Promise in Treating Alcohol Use Disorder
PremiumCompany Announcements
BrainsWay’s Deep TMS Shows Promise in Pain Reduction
PremiumCompany Announcements
BrainsWay Reports Strong Q3 2024 Revenue Growth
PremiumCompany Announcements
BrainsWay’s Strong Q3 Growth and Strategic Expansion---
Bulls Say, Bears Say
Bulls Say
Clinical DataPositive clinical data may drive uptake on multiple fronts with favorable clinical datasets reported by Brainsway.
Market ExpansionEast Asian market penetration advances with the placement of 15 new systems in Taiwan and South Korea.
Bears Say
Investment RisksBrainsWay announced that it has entered into a securities purchase agreement with an affiliate of Valor Equity Partners for a private investment financing expected to result in gross proceeds of ~$20M.
---
Ownership Overview
―
Insiders
0.53% Mutual Funds
6.81% Other Institutional Investors
91.55% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BWAY FAQ
What was Brainsway Ltd’s price range in the past 12 months?
Brainsway Ltd lowest stock price was $4.61 and its highest was $11.79 in the past 12 months.
What is Brainsway Ltd’s market cap?
Brainsway Ltd’s market cap is $214.75M.
When is Brainsway Ltd’s upcoming earnings report date?
Brainsway Ltd’s upcoming earnings report date is Apr 01, 2025 which is in 37 days.
How were Brainsway Ltd’s earnings last quarter?
Brainsway Ltd released its earnings results on Nov 12, 2024. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.01.
Is Brainsway Ltd overvalued?
According to Wall Street analysts Brainsway Ltd’s price is currently Undervalued.
Does Brainsway Ltd pay dividends?
Brainsway Ltd does not currently pay dividends.
What is Brainsway Ltd’s EPS estimate?
Brainsway Ltd’s EPS estimate is 0.02.
How many shares outstanding does Brainsway Ltd have?
Brainsway Ltd has 18,827,324 shares outstanding.
What happened to Brainsway Ltd’s price movement after its last earnings report?
Brainsway Ltd reported an EPS of $0.02 in its last earnings report, beating expectations of $0.01. Following the earnings report the stock price went down -10.185%.
Which hedge fund is a major shareholder of Brainsway Ltd?
Currently, no hedge funds are holding shares in BWAY
---
Brainsway Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$16.00 (48.84% Upside)
$16.00 (48.84% Upside)
Blogger Sentiment
Bullish
BWAY Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
75.15%
12-Months-Change
Fundamentals
Return on Equity
3.52%
Trailing 12-Months
Asset Growth
20.62%
Trailing 12-Months
Company Description
Brainsway Ltd
Brainsway Ltd. engages in the research, development and marketing of medical device for non-invasive treatment of the brain disorders. Its technology enables handling of a wide range of indications through the TMS Deep system developed by the company. Brainsway operates through the following segments: Major depression and Obsessive Compulsive Disorder (OCD). The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.
---
BWAY Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
BrainsWay's earnings call highlighted strong financial performance, including significant revenue growth, a robust cash position bolstered by strategic financing, and positive future guidance. While operating expenses have increased, the company is successfully expanding its global distribution and pursuing promising R&D initiatives. The sentiment of the call is overall positive given the achievements and growth potential despite the mentioned cost increases.Read More>---
BWAY Stock 12 Month Forecast
Average Price Target
$16.00
▲(48.84% Upside)
Technical Analysis
Best Analysts Covering BWAY
1 Year
1 Year Success Rate
11/17 ratings generated profit
1 Year Average Return
+53.75%
assigned a buy rating 10 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 64.71% of your transactions generating a profit, with an average return of +53.75% per trade.
---